Abstract

Various TRP channels act as polymodal sensors of thermal and chemical stimuli, but the mechanisms whereby chemical ligands impact on TRP channel gating are poorly understood. Here we show that AITC (allyl isothiocyanate; mustard oil) and menthol represent two distinct types of ligands at the mammalian cold sensor TRPM8. Kinetic analysis of channel gating revealed that AITC acts by destabilizing the closed channel, whereas menthol stabilizes the open channel, relative to the transition state. Based on these differences, we classify agonists as either type I (menthol-like) or type II (AITC-like), and provide a kinetic model that faithfully reproduces their differential effects. We further demonstrate that type I and type II agonists have a distinct impact on TRPM8 currents and TRPM8-mediated calcium signals in excitable cells. These findings provide a theoretical framework for understanding the differential actions of TRP channel ligands, with important ramifications for TRP channel structure-function analysis and pharmacology.

Article and author information

Author details

  1. Janssens Annelies

    Laboratory of Ion Channel Research, University of Leuven, Leuven, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  2. Maarten Gees

    Laboratory of Ion Channel Research, University of Leuven, Leuven, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  3. Balazs Istvan Toth

    Laboratory of Ion Channel Research, University of Leuven, Leuven, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  4. Debapriya Ghosh

    Laboratory of Ion Channel Research, University of Leuven, Leuven, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  5. Marie Mulier

    Laboratory of Ion Channel Research, University of Leuven, Leuven, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  6. Rudi Vennekens

    Laboratory of Ion Channel Research, University of Leuven, Leuven, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  7. Joris Vriens

    Laboratory of Ion Channel Research, University of Leuven, Leuven, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  8. Karel Talavera

    Laboratory of Ion Channel Research, University of Leuven, Leuven, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  9. Thomas Voets

    Laboratory of Ion Channel Research, University of Leuven, Leuven, Belgium
    For correspondence
    thomas.voets@med.kuleuven.be
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5526-5821

Funding

Fonds Wetenschappelijk Onderzoek (G.0565.07)

  • Thomas Voets

Onderzoeksraad, KU Leuven (PF-TRPLe)

  • Rudi Vennekens
  • Thomas Voets

Belspo (IUAP P7/13)

  • Rudi Vennekens
  • Karel Talavera
  • Thomas Voets

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All experiments were approved by the KU Leuven Ethical Committee Laboratory Animals under project number P192/2014.

Copyright

© 2016, Annelies et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Janssens Annelies
  2. Maarten Gees
  3. Balazs Istvan Toth
  4. Debapriya Ghosh
  5. Marie Mulier
  6. Rudi Vennekens
  7. Joris Vriens
  8. Karel Talavera
  9. Thomas Voets
(2016)
Definition of two agonist types at the mammalian cold-activated channel TRPM8
eLife 5:e17240.
https://doi.org/10.7554/eLife.17240

Share this article

https://doi.org/10.7554/eLife.17240

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Joar Esteban Pinto Torres, Mathieu Claes ... Yann G-J Sterckx
    Research Article

    African trypanosomes are the causative agents of neglected tropical diseases affecting both humans and livestock. Disease control is highly challenging due to an increasing number of drug treatment failures. African trypanosomes are extracellular, blood-borne parasites that mainly rely on glycolysis for their energy metabolism within the mammalian host. Trypanosomal glycolytic enzymes are therefore of interest for the development of trypanocidal drugs. Here, we report the serendipitous discovery of a camelid single-domain antibody (sdAb aka Nanobody) that selectively inhibits the enzymatic activity of trypanosomatid (but not host) pyruvate kinases through an allosteric mechanism. By combining enzyme kinetics, biophysics, structural biology, and transgenic parasite survival assays, we provide a proof-of-principle that the sdAb-mediated enzyme inhibition negatively impacts parasite fitness and growth.

    1. Structural Biology and Molecular Biophysics
    Manming Xu, Sarath Chandra Dantu ... Shozeb Haider
    Research Article

    The relationship between protein dynamics and function is essential for understanding biological processes and developing effective therapeutics. Functional sites within proteins are critical for activities such as substrate binding, catalysis, and structural changes. Existing computational methods for the predictions of functional residues are trained on sequence, structural, and experimental data, but they do not explicitly model the influence of evolution on protein dynamics. This overlooked contribution is essential as it is known that evolution can fine-tune protein dynamics through compensatory mutations either to improve the proteins’ performance or diversify its function while maintaining the same structural scaffold. To model this critical contribution, we introduce DyNoPy, a computational method that combines residue coevolution analysis with molecular dynamics simulations, revealing hidden correlations between functional sites. DyNoPy constructs a graph model of residue–residue interactions, identifies communities of key residue groups, and annotates critical sites based on their roles. By leveraging the concept of coevolved dynamical couplings—residue pairs with critical dynamical interactions that have been preserved during evolution—DyNoPy offers a powerful method for predicting and analysing protein evolution and dynamics. We demonstrate the effectiveness of DyNoPy on SHV-1 and PDC-3, chromosomally encoded β-lactamases linked to antibiotic resistance, highlighting its potential to inform drug design and address pressing healthcare challenges.